Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.0700 (0.21%) ($14.0700 - $14.0700) on Mon. May. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.71% (three month average) | RSI | 54 | Latest Price | $14.0700(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.355% in a week (0% probabilities). VIXM(-35%) VXX(-27%) UNG(-12%) TLT(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.355% (StdDev 2.71%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.35(-1.95%) | 10 Day Moving Average | $14.18(-0.78%) | 20 Day Moving Average | $14.01(0.43%) | To recent high | -32% | To recent low | 6.2% | Market Cap | $1.046b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |